Quantification of Alzheimer-type neurofibrillary lesions by automated image analysis

被引:4
|
作者
McKenzie, JE
Roberts, GW
Royston, MC
机构
[1] CHARING CROSS & WESTMINSTER MED SCH,DEPT PSYCHIAT,LONDON W6 8RF,ENGLAND
[2] SMITHKLINE BEECHAM PHARMACEUT LTD,DEPT MOL NEUROPATHOL,HARLOW CM19 5AW,ESSEX,ENGLAND
来源
NEURODEGENERATION | 1996年 / 5卷 / 03期
关键词
image analysis; quantification; neuropathology; Alz-50;
D O I
10.1006/neur.1996.0033
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Neurofibrillary pathology is seen in a wide variety of disorders such as Alzheimer's disease (AD), progressive supranuclear palsy and the Parkinsonism-dementia amyotrophic lateral sclerosis complex of Guam. To assess the pathological importance of these lesions quantitative studies need to be undertaken. To date, most neuropathological studies have been based on qualitative, or at best semi-quantitative, data reporting the presence or absence of specific lesion types. To obtain such data traditionally involves laborious manual measurements, which rely heavily on the skill of the investigator and tend to have low inter- and intra-rater reliabilities. We have developed a novel analysis technique, using colour image analysis, which can accurately quantify the total amount of neurofibrillary damage present. Furthermore we have developed a set of mathematically defined morphological criteria to allow objective discrimination between the three types of neurofibrillary damage seen in the cortex immunostained with Alz-50. Use of this novel technique provides a reliable, rational means for the classification of neurofibrillary lesions. (C) 1996 Academic Press Limited
引用
收藏
页码:251 / 258
页数:8
相关论文
共 50 条
  • [31] PHARMACOLOGIC MANAGEMENT OF ALZHEIMER-TYPE DEMENTIA
    VOLICER, L
    HERZ, LR
    AMERICAN FAMILY PHYSICIAN, 1985, 32 (01) : 123 - 128
  • [32] SURVIVAL OF OUTPATIENTS WITH ALZHEIMER-TYPE DEMENTIA
    WALSH, JS
    WELCH, HG
    LARSON, EB
    ANNALS OF INTERNAL MEDICINE, 1990, 113 (06) : 429 - 434
  • [33] Diagnosis and treatment of Alzheimer-type dementia
    Hampel, H
    Padberg, F
    Buch, K
    Unger, J
    Stübner, S
    Möller, HJ
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1999, 124 (05) : 124 - 129
  • [34] Perspectives of pharmacotherapy of Alzheimer-type dementia
    Vetulani, J
    PHARMACOPSYCHIATRY, 2002, 35 (05) : XVI - XVII
  • [35] The cognitive neuropsychology of Alzheimer-type dementia
    McMordie, WR
    CONTEMPORARY PSYCHOLOGY, 1998, 43 (08): : 569 - 569
  • [36] CONSTRUCTIONAL APRAXIA IN ALZHEIMER-TYPE DEMENTIA
    RAINVILLE, C
    CARDU, B
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1988, 15 (02) : 230 - 230
  • [37] Alzheimer-type of pathological changes in Chinese
    Ng, HK
    Cheng, Y
    Poon, WS
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 1997, 145 (01) : 97 - 103
  • [38] Alzheimer-type pathology in Down syndrome
    Mölsä, P
    JOURNAL OF INTELLECTUAL DISABILITY RESEARCH, 2000, 44 : 398 - 398
  • [39] EEC MAPPING IN ALZHEIMER-TYPE DEMENTIAS
    IZNAK, AF
    CHAYANOV, NV
    GAVRILOVA, SI
    MIKHAILOVA, NM
    SELEZNEVA, ND
    KALYN, YB
    KOLYKHALOV, IV
    VESTNIK ROSSIISKOI AKADEMII MEDITSINSKIKH NAUK, 1992, (08): : 39 - 41
  • [40] CORTICAL NEUROCHEMISTRY IN ALZHEIMER-TYPE DEMENTIA
    CROSS, AJ
    CROW, TJ
    PETERS, TJ
    PROGRESS IN BRAIN RESEARCH, 1986, 70 : 153 - 169